Trial Profile
A Prospective, Multicenter, Randomized, Open-label Trial to Evaluate Efficacy and Safety of 5mg Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention With BiomatrixTM Stent
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel; Umirolimus
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms BEAUTY-II
- 04 Aug 2017 New trial record